|
2022-06-17 |
2022-06-17 |
S
Sale
|
Non-Executive Director
|
44,932
-25.7%
479.91
US$2,990,556
|
44,932
-25.7%
|
479.91
|
US$2,990,556
|
|
|
2022-06-17 |
2022-06-17 |
B
Purchase
|
Large shareholder
|
13,496
+28.5%
275.22
US$2,049,605
|
13,496
+28.5%
|
275.22
|
US$2,049,605
|
|
|
2021-06-17 |
2021-06-15 |
S
Sale
|
Chief Administrative Officer
Officer
|
30,637
+8.4%
137.59
US$3,124,474
|
30,637
+8.4%
|
137.59
|
US$3,124,474
|
|
|
2021-05-17 |
2021-05-13 |
B
Purchase
|
See Remarks
Officer
|
1,000
+0.7%
31.40
US$31,400
|
1,000
+0.7%
|
31.40
|
US$31,400
|
|
|
2021-04-28 |
2021-04-28 |
S
Sale
|
Chief Medical Officer
Officer
|
100,000
-21.2%
24.50
US$2,450,000
|
100,000
-21.2%
|
24.50
|
US$2,450,000
|
|
|
2021-04-28 |
2021-04-28 |
B
Purchase
|
Large shareholder
|
100,000
+0.9%
24.50
US$2,450,000
|
100,000
+0.9%
|
24.50
|
US$2,450,000
|
|
|
2021-04-06 |
2021-04-01 |
S
Sale
|
Large shareholder
|
1,638,045
-13.3%
24.50
US$40,132,102
|
1,638,045
-13.3%
|
24.50
|
US$40,132,102
|
|
|
2020-09-15 |
2020-09-14 |
B
Purchase
|
Executive Chairman and Co-CEO
Executive Director
|
1,000
+6.1%
17.20
US$17,204
|
1,000
+6.1%
|
17.20
|
US$17,204
|
|
|
2020-09-15 |
2020-09-14 |
B
Purchase
|
See Remarks
Officer
|
5,000
+13.2%
17.23
US$86,168
|
5,000
+13.2%
|
17.23
|
US$86,168
|
|
|
2020-09-15 |
2020-09-14 |
B
Purchase
|
Executive Chairman and Co-CEO
Executive Director
|
5,000
+13.2%
17.23
US$86,168
|
5,000
+13.2%
|
17.23
|
US$86,168
|
|
|
2020-09-15 |
2020-09-14 |
B
Purchase
|
See Remarks
Officer
|
1,000
+6.1%
17.20
US$17,204
|
1,000
+6.1%
|
17.20
|
US$17,204
|
|
|
2020-09-15 |
2020-09-14 |
B
Purchase
|
President and Co-CEO
Executive Director
|
5,000
+0.7%
17.28
US$86,381
|
5,000
+0.7%
|
17.28
|
US$86,381
|
|
|
2020-09-15 |
2020-09-11 |
S
Sale
|
Chief Medical Officer
Officer
|
602
-0.1%
18.00
US$10,836
|
602
-0.1%
|
18.00
|
US$10,836
|
|
|
2020-09-14 |
2020-09-10 |
B
Purchase
|
See Remarks
Officer
|
5,000
+15.2%
17.60
US$88,000
|
5,000
+15.2%
|
17.60
|
US$88,000
|
|
|
2020-09-10 |
2020-09-09 |
B
Purchase
|
President and Co-CEO
Executive Director
|
5,000
+0.3%
17.85
US$89,250
|
5,000
+0.3%
|
17.85
|
US$89,250
|
|
|
2020-09-10 |
2020-09-09 |
B
Purchase
|
Executive Chairman and Co-CEO
Executive Director
|
5,000
+15.2%
17.60
US$88,000
|
5,000
+15.2%
|
17.60
|
US$88,000
|
|
|
2020-09-10 |
2020-09-09 |
S
Sale
|
Chief Medical Officer
Officer
|
7,484
-1.6%
18.00
US$134,712
|
7,484
-1.6%
|
18.00
|
US$134,712
|
|
|
2020-09-10 |
2020-09-08 |
S
Sale
|
Chief Medical Officer
Officer
|
5,783
-1.2%
18.15
US$104,949
|
5,783
-1.2%
|
18.15
|
US$104,949
|
|
|
2020-08-31 |
2020-08-27 |
B
Purchase
|
See Remarks
Executive Director
|
5,000
+0.3%
18.34
US$91,700
|
5,000
+0.3%
|
18.34
|
US$91,700
|
|
|
2020-08-31 |
2020-08-27 |
B
Purchase
|
Executive Chairman and Co-CEO
Executive Director
|
5,000
+0.3%
18.34
US$91,700
|
5,000
+0.3%
|
18.34
|
US$91,700
|
|
|
2020-08-31 |
2020-08-27 |
B
Purchase
|
President and Co-CEO
Executive Director
|
5,000
+0.3%
18.23
US$91,150
|
5,000
+0.3%
|
18.23
|
US$91,150
|
|
|
2020-06-12 |
2020-06-11 |
B
Purchase
|
Chief Financial Officer
Officer
|
2,040
+28.5%
14.90
US$30,396
|
2,040
+28.5%
|
14.90
|
US$30,396
|
|
|
2020-06-09 |
2020-06-08 |
S
Sale
|
Chief Medical Officer
Officer
|
4,200
-0.9%
17.09
US$71,778
|
4,200
-0.9%
|
17.09
|
US$71,778
|
|
|
2020-06-09 |
2020-06-05 |
S
Sale
|
Chief Medical Officer
Officer
|
29,185
-5.6%
17.23
US$502,858
|
29,185
-5.6%
|
17.23
|
US$502,858
|
|
|
2020-06-05 |
2020-06-03 |
S
Sale
|
Chief Medical Officer
Officer
|
2,683
-0.5%
18.00
US$48,294
|
2,683
-0.5%
|
18.00
|
US$48,294
|
|
|
2020-01-15 |
2020-01-15 |
PP
Planned purchase
|
Large shareholder
|
4,298
+0.0%
18.34
US$78,825
|
4,298
+0.0%
|
18.34
|
US$78,825
|
|
|
2020-01-14 |
2020-01-14 |
PP
Planned purchase
|
Large shareholder
|
7,130
+0.0%
17.81
US$126,985
|
7,130
+0.0%
|
17.81
|
US$126,985
|
|
|
2020-01-14 |
2020-01-13 |
PP
Planned purchase
|
Large shareholder
|
5,469
+0.0%
17.42
US$95,270
|
5,469
+0.0%
|
17.42
|
US$95,270
|
|
|
2019-12-18 |
2019-12-18 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
15,000
+0.1%
18.50
US$277,500
|
15,000
+0.1%
|
18.50
|
US$277,500
|
|
|
2019-12-17 |
2019-12-17 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
15,000
+0.1%
18.47
US$277,050
|
15,000
+0.1%
|
18.47
|
US$277,050
|
|
|
2019-12-16 |
2019-12-16 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
15,000
+0.1%
18.94
US$284,100
|
15,000
+0.1%
|
18.94
|
US$284,100
|
|
|
2019-12-13 |
2019-12-13 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
35,718
+0.2%
18.32
US$654,354
|
35,718
+0.2%
|
18.32
|
US$654,354
|
|
|
2019-12-12 |
2019-12-12 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
23,673
+0.1%
18.06
US$427,534
|
23,673
+0.1%
|
18.06
|
US$427,534
|
|
|
2019-12-12 |
2019-12-11 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
27,537
+0.2%
17.48
US$481,347
|
27,537
+0.2%
|
17.48
|
US$481,347
|
|
|
2019-12-10 |
2019-12-10 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
23,462
+0.1%
16.75
US$392,988
|
23,462
+0.1%
|
16.75
|
US$392,988
|
|
|
2019-12-09 |
2019-12-09 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
38,600
+0.2%
17.60
US$679,360
|
38,600
+0.2%
|
17.60
|
US$679,360
|
|
|
2019-12-06 |
2019-12-06 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
32,363
+0.2%
18.95
US$613,279
|
32,363
+0.2%
|
18.95
|
US$613,279
|
|
|
2019-12-05 |
2019-12-05 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
13,595
+0.1%
18.64
US$253,411
|
13,595
+0.1%
|
18.64
|
US$253,411
|
|
|
2019-12-06 |
2019-12-04 |
B
Purchase
|
Eng Michael F.
Non-Executive Director
|
1,890
+63.0%
18.48
US$34,927
|
1,890
+63.0%
|
18.48
|
US$34,927
|
|
|
2019-12-04 |
2019-12-04 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
18,539
+0.1%
18.36
US$340,376
|
18,539
+0.1%
|
18.36
|
US$340,376
|
|
|
2019-12-03 |
2019-12-03 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
20,000
+0.1%
18.24
US$364,800
|
20,000
+0.1%
|
18.24
|
US$364,800
|
|
|
2019-12-02 |
2019-12-02 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
18,602
+0.1%
17.94
US$333,720
|
18,602
+0.1%
|
17.94
|
US$333,720
|
|
|
2019-12-02 |
2019-11-29 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
6,500
+0.0%
18.46
US$119,990
|
6,500
+0.0%
|
18.46
|
US$119,990
|
|
|
2019-11-27 |
2019-11-27 |
B
Purchase
|
Large shareholder
|
2,500
+0.0%
18.22
US$45,550
|
2,500
+0.0%
|
18.22
|
US$45,550
|
|
|
2019-11-27 |
2019-11-26 |
B
Purchase
|
Large shareholder
|
10,000
+0.1%
17.96
US$179,600
|
10,000
+0.1%
|
17.96
|
US$179,600
|
|
|
2019-11-25 |
2019-11-25 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
33,000
+0.2%
17.32
US$571,560
|
33,000
+0.2%
|
17.32
|
US$571,560
|
|
|
2019-11-22 |
2019-11-22 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
25,000
+0.1%
17.79
US$444,750
|
25,000
+0.1%
|
17.79
|
US$444,750
|
|
|
2019-11-21 |
2019-11-21 |
B
Purchase
|
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSION MEDICAL Corp
Large shareholder
|
1,900
+0.0%
17.50
US$33,250
|
1,900
+0.0%
|
17.50
|
US$33,250
|
|
|
2019-11-20 |
2019-11-20 |
B
Purchase
|
Large shareholder
|
12,100
+0.1%
17.28
US$209,088
|
12,100
+0.1%
|
17.28
|
US$209,088
|
|
|
2019-11-20 |
2019-11-19 |
B
Purchase
|
Large shareholder
|
18,203
+0.1%
16.17
US$294,343
|
18,203
+0.1%
|
16.17
|
US$294,343
|
|
|
2019-11-18 |
2019-11-14 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman and Co-CEO
Executive Director
|
10,000
+0.6%
14.67
US$146,700
|
10,000
+0.6%
|
14.67
|
US$146,700
|
|
|
2019-11-15 |
2019-11-14 |
B
Purchase
|
President and Co-CEO
Executive Director
|
10,000
+0.6%
14.84
US$148,400
|
10,000
+0.6%
|
14.84
|
US$148,400
|
|
|
2019-10-29 |
2019-10-08 |
B
Purchase
|
Executive Chairman and Co-CEO
Executive Director
|
5,000
+0.3%
15.55
US$77,750
|
5,000
+0.3%
|
15.55
|
US$77,750
|
|
|
2019-09-17 |
2019-09-13 |
S
Sale
|
Chief Medical Officer
|
27,350
-5.0%
19.77
US$540,710
|
27,350
-5.0%
|
19.77
|
US$540,710
|
|
|
2019-09-17 |
2019-09-12 |
S
Sale
|
Chief Medical Officer
|
13,746
-2.4%
20.14
US$276,844
|
13,746
-2.4%
|
20.14
|
US$276,844
|
|
|
2019-09-16 |
2019-09-12 |
B
Purchase
|
|
2,000
+200.0%
20.28
US$40,560
|
2,000
+200.0%
|
20.28
|
US$40,560
|
|
|
2019-09-17 |
2019-09-11 |
S
Sale
|
Chief Medical Officer
|
43,704
-7.2%
20.14
US$880,199
|
43,704
-7.2%
|
20.14
|
US$880,199
|
|
|
2019-08-20 |
2019-08-19 |
B
Purchase
|
Eng Michael F.
Non-Executive Director
|
1,000
+inf%
15.97
US$15,970
|
1,000
+inf%
|
15.97
|
US$15,970
|
|
|
2019-08-20 |
2019-08-16 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman
Executive Director
|
563
+0.0%
16.35
US$9,205
|
563
+0.0%
|
16.35
|
US$9,205
|
|
|
2019-08-20 |
2019-08-16 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman
Executive Director
|
437
+0.0%
16.35
US$7,145
|
437
+0.0%
|
16.35
|
US$7,145
|
|
|
2019-08-20 |
2019-08-16 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman
Executive Director
|
1,500
+0.1%
16.25
US$24,375
|
1,500
+0.1%
|
16.25
|
US$24,375
|
|
|
2019-08-20 |
2019-08-15 |
B
Purchase
|
Lam Thomas S.
Chief Executive Officer
Executive Director
|
6,000
+0.4%
16.19
US$97,140
|
6,000
+0.4%
|
16.19
|
US$97,140
|
|
|
2019-08-20 |
2019-08-15 |
B
Purchase
|
Lam Thomas S.
Chief Executive Officer
Executive Director
|
4,000
+0.2%
15.57
US$62,280
|
4,000
+0.2%
|
15.57
|
US$62,280
|
|
|
2019-08-20 |
2019-08-15 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman
Executive Director
|
1,500
+0.1%
15.25
US$22,875
|
1,500
+0.1%
|
15.25
|
US$22,875
|
|
|
2019-08-20 |
2019-08-14 |
B
Purchase
|
Lam Thomas S.
Chief Executive Officer
Executive Director
|
7,200
+0.4%
16.85
US$121,320
|
7,200
+0.4%
|
16.85
|
US$121,320
|
|
|
2019-08-20 |
2019-08-14 |
B
Purchase
|
Young Albert WaiChow
Co-Chief Medical Officer
Officer
|
5,000
+0.5%
15.01
US$75,050
|
5,000
+0.5%
|
15.01
|
US$75,050
|
|
|
2019-08-20 |
2019-08-14 |
B
Purchase
|
Sim Kenneth T.
Executive Chairman
Executive Director
|
2,000
+0.1%
16.23
US$32,460
|
2,000
+0.1%
|
16.23
|
US$32,460
|
|
|
2019-06-18 |
2019-06-14 |
B
Purchase
|
|
100
+inf%
16.31
US$1,631
|
100
+inf%
|
16.31
|
US$1,631
|
|
|
2019-06-14 |
2019-06-12 |
B
Purchase
|
Chief Financial Officer
|
2,040
+127.6%
14.72
US$30,029
|
2,040
+127.6%
|
14.72
|
US$30,029
|
|
|
2019-06-13 |
2019-06-12 |
B
Purchase
|
Executive Chairman
Executive Director
|
1,300
+0.1%
14.45
US$18,785
|
1,300
+0.1%
|
14.45
|
US$18,785
|
|
|
2019-06-13 |
2019-06-11 |
B
Purchase
|
Executive Chairman
Executive Director
|
5,696
+0.3%
14.51
US$82,649
|
5,696
+0.3%
|
14.51
|
US$82,649
|
|
|
2019-06-13 |
2019-06-11 |
B
Purchase
|
|
10,000
+inf%
14.13
US$141,300
|
10,000
+inf%
|
14.13
|
US$141,300
|
|
|
2019-06-13 |
2019-06-11 |
B
Purchase
|
Chief Executive Officer
Executive Director
|
6,900
+0.4%
14.64
US$101,016
|
6,900
+0.4%
|
14.64
|
US$101,016
|
|
|
2019-06-05 |
2019-06-04 |
S
Sale
|
Co-Chief Medical Officer
|
38,051
-5.9%
16.01
US$609,056
|
38,051
-5.9%
|
16.01
|
US$609,056
|
|
|
2019-06-05 |
2019-06-03 |
S
Sale
|
Co-Chief Medical Officer
|
46,949
-6.8%
16.64
US$781,114
|
46,949
-6.8%
|
16.64
|
US$781,114
|
|